PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
  • User avatar
#1853
Some agents have proven teratogenic potential. These agents are summarized. Although the effects of such agents are potentially variable and predictable, their use should be very limited or avoided during pregnancy.

Category D agents have proven teratogenic potential but may, under certain circumstances, be indicated. Prior to using any category D agent, providers should perform a careful review of indications, duration of therapy, all potential.effects, and all potential alternatives to the proposed therapy.

In addition,patients should be informed of these considerations, allowing for informed con-
sent to the proposed therapy. Category X medications have proven teratogenic potential and use should be avoided in pregnancy


Proven Human Teratogens


Category D

Cyclophosphamide
Lithium
Paramethadione
Phenytoin
Barbiturates
Benzodiazepines
Systemic retinoids
Tetracycline
Trimethodione
Valproic acid
Warfarin

Category X

Thalidomide
Danazol
Misoprostil
Diethylstilbesterol
Similar Topics
Topics Statistics Last post
2 Replies 
2531 Views
by amirsiddiqui
0 Replies 
1169 Views
by Admin
0 Replies 
1745 Views
by Freelancer
0 Replies 
884 Views
by vasanth
0 Replies 
1152 Views
by nandan

Check Here to get the updates on oncology Phar[…]

When will the new (2022) batch start for fellowshi[…]

Vacancy for the post of Assistant Professor in the[…]

Clinical pharmacist vacancy in Fortis Hospital, Mu[…]

PharmD Info - Highlights